SUMMARY
This report describes the results of a multicentre collaborative study comparing the safety and efficacy of alprazolam with imipramine in patients suffering from major depressive disorder. Two hundred and eight patients diagnosed as major depression as per DSM-III criteria were randomly allocated to alprazolam (N= 105) or imipramine (N = 103) in a double-blind fashion. Detailed assessments were carried out for a period of six weeks. Results revealed that alprazolam was as effective as imipramine as an antidepressant. Side effects were less frequently reported with alprazolam.
Full Text
The Full Text of this article is available as a PDF (193.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Feighner J. P., Aden G. C., Fabre L. F., Rickels K., Smith W. T. Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA. 1983 Jun 10;249(22):3057–3064. [PubMed] [Google Scholar]
- Feighner J. P. Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression. Mod Probl Pharmacopsychiatry. 1982;18:196–212. [PubMed] [Google Scholar]
- Feighner J. P., Meredith C. H., Frost N. R., Chammas S., Hendrickson G. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder. Acta Psychiatr Scand. 1983 Oct;68(4):223–233. doi: 10.1111/j.1600-0447.1983.tb07003.x. [DOI] [PubMed] [Google Scholar]
- Feighner J. P., Robins E., Guze S. B., Woodruff R. A., Jr, Winokur G., Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972 Jan;26(1):57–63. doi: 10.1001/archpsyc.1972.01750190059011. [DOI] [PubMed] [Google Scholar]
- Flamenbaum W., Friedman R. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic. Pharmacotherapy. 1982 Jul-Aug;2(4):213–222. doi: 10.1002/j.1875-9114.1982.tb03188.x. [DOI] [PubMed] [Google Scholar]
- Fyer A. J., Liebowitz M. R., Gorman J. M., Campeas R., Levin A., Davies S. O., Goetz D., Klein D. F. Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry. 1987 Mar;144(3):303–308. doi: 10.1176/ajp.144.3.303. [DOI] [PubMed] [Google Scholar]
- HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x. [DOI] [PubMed] [Google Scholar]
- Juergens S. M., Morse R. M. Alprazolam dependence in seven patients. Am J Psychiatry. 1988 May;145(5):625–627. doi: 10.1176/ajp.145.5.625. [DOI] [PubMed] [Google Scholar]
- Lydiard R. B., Laraia M. T., Ballenger J. C., Howell E. F. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry. 1987 May;144(5):664–665. doi: 10.1176/ajp.144.5.664. [DOI] [PubMed] [Google Scholar]
- Raskin A., Schulterbrandt J. G., Reatig N., McKeon J. J. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients. Arch Gen Psychiatry. 1970 Aug;23(2):164–173. doi: 10.1001/archpsyc.1970.01750020068009. [DOI] [PubMed] [Google Scholar]
- Rickels K., Chung H. R., Csanalosi I. B., Hurowitz A. M., London J., Wiseman K., Kaplan M., Amsterdam J. D. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Arch Gen Psychiatry. 1987 Oct;44(10):862–866. doi: 10.1001/archpsyc.1987.01800220024005. [DOI] [PubMed] [Google Scholar]
- Rickels K., Feighner J. P., Smith W. T. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Arch Gen Psychiatry. 1985 Feb;42(2):134–141. doi: 10.1001/archpsyc.1985.01790250028004. [DOI] [PubMed] [Google Scholar]